Top Markets
Coin of the day
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Rank in Stocks #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Share Price
$4.66
Market Cap
$43.92M
Change (1 day)
-0.63%
Change (1 year)
338.04%
Country
FR
Trade Theranexus Société Anonyme (ALTHX)

Category

Operating Margin for Theranexus Société Anonyme (ALTHX)
Operating Margin as of July 2026 TTM: -1,251.59%
According to Theranexus Société Anonyme latest financial reports and stock price the company's current Operating Margin (TTM) is -1,251.59%. At the end of 2023 the company had an Operating Margin of -2,579.44%.
Operating Margin history for Theranexus Société Anonyme from 2015 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -1,251.59% 494.13%
2024 -210.66% -91.83%
2023 -2,579.44% 71.04%
2022 -1,508.08% -99.90%
2021 -1,580,201.00% 72,713.28%
2020 -2,170.21% 54.10%
2019 -1,408.28% -78.00%
2018 -6,401.73% 248.39%
2017 -1,837.54% -19.16%
2016 -2,272.96% 1,042.94%
2015 -198.87% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
45.30% -100.04%
DK
38.97% -100.03%
US
24.32% -100.02%
US
25.32% -100.02%
BE
25.64% -100.02%
NL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.